A year after launching the Cost Plus Drugs company, billionaire entrepreneur Mark Cuban has reaffirmed his intention to disrupt the generics sector, albeit in partnership with US off-patent industry players.
The company’s model is based on the idea of a transparent cost price for a given product, with consistent and...




